Close menu




December 16th, 2020 | 10:33 CET

DOW, Henkel, Royal Helium - Chemistry learns sustainability

  • Investments
Photo credits: pixabay.com

The chemical sector is entering a new era. Value chains are being reshaped as sustainability, along with economic and geopolitical shifts, new technologies, and changing consumer demands challenge the bottom line and future profitability of companies. Covid-19 has led to even greater complexity and caused significant shifts in supply and demand. However, sustainability factors and ESG criteria also offer growth and differentiation opportunities for companies that redefine their value chains and business models, adapt to the circular economy, seize the opportunities of digital technology, and upskill their employees to the best of their abilities.

time to read: 3 minutes | Author: André Will-Laudien
ISIN: CA78029U2056 , DE0006048432 , US2605571031

Table of contents:


    Dow Inc.- chemical giant on new paths

    Dow Inc., formerly known as Dow Chemical, recently announced that it has joined with companies from around the world to form a new consortium under the acronym CELAB: "Toward a Circular Economy for Labels." CELAB is a well-intentioned industry initiative started by self-adhesive label manufacturers with the goal of creating a greater circular economy for their products by improving and promoting the recycling of matrix and release paper substrates.

    With the formation of CELAB, Dow joins other industry leaders to facilitate collaboration on a global scale, promote regional initiatives and implement universal adoption of industry best practices for greater sustainability. Success is guaranteed through the collaboration between industry players across the value chain. Dow Inc. is the 2019 merger of Dow Chemical and Du Pont de Nemours, which currently employs 37,000 people in agricultural chemicals, plastics and speciality chemicals.

    With a price-to-sales ratio of just 1 and a dividend yield of 5.3%, Dow Inc. is an absolute standard old economy stock. With a share price of USD 53.7, it is aiming for new highs in a positive trend.

    Henkel - Washing 4.0

    Henkel has opened a state-of-the-art, fully automated warehouse for laundry detergents and household cleaners at its production site in Montornès del Vallès, in Spain near Barcelona. The Company made an investment of EUR 22 million in the 24,000-square-meter warehouse, which will serve as an essential distribution hub for southern Europe. The new logistics centre is another example of Henkel's strategy to combine Industry 4.0 and smart factory concepts. The facility will be based on digitization and robotization. It will use cutting-edge technology in logistics and will define new environmental standards. In this way, the Company is improving the resource efficiency of its supply chain, time-to-market and streamlining processes. Henkel aims to become a climate-neutral company by 2040.

    Henkel's share price recovery is still a long way from the 2017 highs of around EUR 125, with the share price recently rising from EUR 68 to EUR 89. However, earnings growth is expected to return to 15% in 2021. In the last 3 years, this had slumped by almost 40%. The Company has a market value of EUR 39 billion and is currently practicing breaking out of a three-year downtrend. With a target price of EUR 106, Goldman Sachs is already positive - we hope this is a good sign…

    Royal Helium - With full cash into the new year

    Royal Helium Ltd. is focused on the exploration and development of a significant helium production project in southern Saskatchewan. Helium is an essential industrial gas for the chemical industry. With over 400,000 hectares of prospective land held under permits, leases and applications, Royal is one of the largest helium landholders in North America.

    Royal Helium's projects have been methodically studied for over two years for their production potential and reviewed by geologists and engineers. A feasibility study will now be carried out, and the project will be developed further, as the demand for helium has grown by leaps and bounds. To take the next steps, RHI has entered into an agreement with a consortium of underwriters led by Cormark Securities Inc. for a private placement of 20 million units at a price of 22 cents per unit. This amount flushes around CAD 5 million into the coffers, which means that the Company is financed through for the future work and can tackle the year 2021 dynamically.

    The Company currently has a capitalization of only CAD 15.2 million at a price of CAD 0.26 per share. The outlook remains very promising, not least because there are currently only a few new helium developments, and demand is leading to rising prices. Potential buyers are likely to have already positioned themselves in the recent capital increase.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on May 10th, 2022 | 11:54 CEST

    GreenTech stocks are on the rise! Buy now: BASF, Meta Materials, Nordex, Siemens Energy

    • GreenTech
    • Technology
    • Investments

    The distortions on the capital markets can hardly be topped at the moment. The nickel price has risen by 300%, only to drop by 70% again. And all this in only 48 hours. There are countless examples in the current stock market environment that are historically unparalleled. In just 2 months, the Bund Future fell from 178 to 151, a loss of 16% in the 10-year Bund. In parallel, the capital market interest rate rose from minus 0.45% to a whopping plus 1.15%. So interest rates are back, inflation is spreading, and supply deficits continue to fuel the underlying stagflation scenario! One major trend should bounce back after the end of the many corrections: GreenTech! Here is a selection of interesting stocks.

    Read

    Commented by Carsten Mainitz on May 10th, 2022 | 10:39 CEST

    Zalando, Aspermont, SAP - Corona and back, the stock rebound is coming!

    • Digitization
    • Investments
    • Technology

    What would society and the economy look like without digitization? The Internet, software and smartphones have become a matter of everyday life and form the basis for communication and interaction. Corona has been an accelerator in many ways. On the other hand, pandemics and war clearly show us the limits of supposedly predictable growth with scarcity prices and supply chain disruptions. At a reduced price level, it is worth looking at "digitization stocks" that offer good opportunities.

    Read

    Commented by Juliane Zielonka on May 5th, 2022 | 12:57 CEST

    Bayer, NervGen, Adler Group - Pharma and Real Estate, management in focus

    • Biotechnology
    • Pharma
    • Investments

    Corporate giant Bayer is collaborating with Charité Berlin to cure genetic diseases in the future. A paradox? Big Pharma thrives on alleviating symptoms but not curing diseases. Things will soon look different. The biotech company NervGen is also dedicated to curing diseases. The approach here: reverse degenerative nerve conditions through self-healing. Specifically, this means helping individuals with paraplegia who are wheelchair-bound reconnect their neural pathways. The Company is in the clinical trials phase and was started by a co-founder who witnessed a dramatic accident. One cannot speak of an accident at the real estate company Adler Group. Four board members have resigned after auditor KPMG refused to give its OK for the annual financial statements. Can management regain the confidence of shareholders?

    Read